VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 135 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,173 | -31.7% | 1,461 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $23,683 | -2.6% | 1,461 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,326 | +3.5% | 1,461 | -41.6% | 0.00% | 0.0% |
| Q4 2022 | $23,500 | +235.7% | 2,500 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +600.0% | 2,500 | +1208.9% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 191 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 191 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 191 | +9450.0% | 0.00% | – |
| Q1 2020 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 2 | -98.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 102 | -1.0% | 0.00% | – |
| Q1 2019 | $1,000 | -80.0% | 103 | -82.8% | 0.00% | – |
| Q4 2018 | $5,000 | +150.0% | 600 | +500.0% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
| Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
| Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
| Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
| Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
| DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
| 5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
| Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |